Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.
Standard
Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. / Piso, Pompiliu; Arnold, Dirk.
in: DTSCH ARZTEBL INT, Jahrgang 108, Nr. 47, 47, 2011, S. 802-808.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.
AU - Piso, Pompiliu
AU - Arnold, Dirk
PY - 2011
Y1 - 2011
N2 - 15% to 20% of patients with metastatic colorectal cancer show isolated peritoneal carcinomatosis with significat clinical relevance. Their prognosis is poor, with a reported mean survival of less than one year. Moreover, there is a lack of knowledge regarding treatment optimally tailored to individual patients.
AB - 15% to 20% of patients with metastatic colorectal cancer show isolated peritoneal carcinomatosis with significat clinical relevance. Their prognosis is poor, with a reported mean survival of less than one year. Moreover, there is a lack of knowledge regarding treatment optimally tailored to individual patients.
KW - Humans
KW - Antineoplastic Agents/therapeutic use
KW - Carcinoma/secondary/therapy
KW - Colorectal Neoplasms/therapy
KW - Combined Modality Therapy/methods
KW - Digestive System Surgical Procedures/methods
KW - Peritoneal Neoplasms/therapy
KW - Humans
KW - Antineoplastic Agents/therapeutic use
KW - Carcinoma/secondary/therapy
KW - Colorectal Neoplasms/therapy
KW - Combined Modality Therapy/methods
KW - Digestive System Surgical Procedures/methods
KW - Peritoneal Neoplasms/therapy
M3 - SCORING: Journal article
VL - 108
SP - 802
EP - 808
JO - DTSCH ARZTEBL INT
JF - DTSCH ARZTEBL INT
SN - 1866-0452
IS - 47
M1 - 47
ER -
